Original language | English |
---|---|
Pages (from-to) | 280-287 |
Number of pages | 8 |
Journal | European Journal of Nuclear Medicine and Molecular Imaging |
Volume | 46 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2019 |
Keywords
- Amyloid
- Amyloid tracer
- Florbetapir
- Multiple sclerosis
- PET
- White matter
- amyloid beta protein[1-42]
- florbetapir f 18
- amyloid beta protein
- adult
- anterior cingulate
- Article
- brain size
- cerebrospinal fluid
- clinical article
- clinical assessment
- comparative study
- controlled study
- damaged white matter
- disease activity
- disease duration
- disease exacerbation
- Expanded Disability Status Scale
- female
- human
- isoelectric focusing
- low drug dose
- lumbar puncture
- male
- mean standardized uptake value
- middle aged
- multiple sclerosis
- neurologic examination
- neuropsychological test
- normal appearing white matter
- nuclear magnetic resonance imaging
- oncological parameters
- paced auditory serial addition test
- positron emission tomography
- posterior cingulate
- precuneus
- superior parietal lobule
- symbol digit modalities test
- temporal lobe
- white matter
- young adult
- diagnostic imaging
- metabolism
- pathology
- reference value
- standards
- Adult
- Amyloid beta-Peptides
- Disease Progression
- Female
- Humans
- Male
- Middle Aged
- Multiple Sclerosis
- Positron-Emission Tomography
- Reference Values
- White Matter
- Young Adult
Cite this
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes. / Pietroboni, A.M.; Carandini, T.; Colombi, Annalisa; Mercurio, M.; Ghezzi, L.; Giulietti, G.; Scarioni, M.; Arighi, A.; Fenoglio, C.; De Riz, M.A.; Fumagalli, G.G.; Basilico, P.; Serpente, M.; Bozzali, M.; Scarpini, E.; Galimberti, D.; Marotta, G.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 46, No. 2, 2019, p. 280-287.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes
AU - Pietroboni, A.M.
AU - Carandini, T.
AU - Colombi, Annalisa
AU - Mercurio, M.
AU - Ghezzi, L.
AU - Giulietti, G.
AU - Scarioni, M.
AU - Arighi, A.
AU - Fenoglio, C.
AU - De Riz, M.A.
AU - Fumagalli, G.G.
AU - Basilico, P.
AU - Serpente, M.
AU - Bozzali, M.
AU - Scarpini, E.
AU - Galimberti, D.
AU - Marotta, G.
N1 - Export Date: 17 June 2019 CODEN: EJNMA Correspondence Address: Pietroboni, A.M.; Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via F. Sforza 35, Italy; email: pb.anna@libero.it
PY - 2019
Y1 - 2019
KW - Amyloid
KW - Amyloid tracer
KW - Florbetapir
KW - Multiple sclerosis
KW - PET
KW - White matter
KW - amyloid beta protein[1-42]
KW - florbetapir f 18
KW - amyloid beta protein
KW - adult
KW - anterior cingulate
KW - Article
KW - brain size
KW - cerebrospinal fluid
KW - clinical article
KW - clinical assessment
KW - comparative study
KW - controlled study
KW - damaged white matter
KW - disease activity
KW - disease duration
KW - disease exacerbation
KW - Expanded Disability Status Scale
KW - female
KW - human
KW - isoelectric focusing
KW - low drug dose
KW - lumbar puncture
KW - male
KW - mean standardized uptake value
KW - middle aged
KW - multiple sclerosis
KW - neurologic examination
KW - neuropsychological test
KW - normal appearing white matter
KW - nuclear magnetic resonance imaging
KW - oncological parameters
KW - paced auditory serial addition test
KW - positron emission tomography
KW - posterior cingulate
KW - precuneus
KW - superior parietal lobule
KW - symbol digit modalities test
KW - temporal lobe
KW - white matter
KW - young adult
KW - diagnostic imaging
KW - metabolism
KW - pathology
KW - reference value
KW - standards
KW - Adult
KW - Amyloid beta-Peptides
KW - Disease Progression
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Multiple Sclerosis
KW - Positron-Emission Tomography
KW - Reference Values
KW - White Matter
KW - Young Adult
U2 - 10.1007/s00259-018-4182-1
DO - 10.1007/s00259-018-4182-1
M3 - Article
VL - 46
SP - 280
EP - 287
JO - European Journal of Pediatrics
JF - European Journal of Pediatrics
SN - 0340-6199
IS - 2
ER -